CSIMarket
 

Old Ayala Inc   (AYLA)

Old Ayala Inc 's

Competitiveness




 

AYLA Sales vs. its Competitors Q4 2022







Revenue Growth Comparisons




Net Income Comparison


Old Ayala Inc recorded a net loss, as well as most of its competitors.

<<  AYLA Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Old Ayala Inc




Lixte Biotechnology Holdings Inc
Share Performance



-20.12%
This Quarter



Lixte Biotechnology Holdings Inc
Profile

Lixte Biotechnology Holdings Inc is a biotech company that focuses on the discovery and development of novel drugs for the treatment of cancer. They primarily operate by conducting pre-clinical and clinical studies, as well as collaborating with research institutions and pharmaceutical companies to advance their drug candidates.

More about Lixte Biotechnology Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 54.575 mill. $ - mill. $ -8.856 mill.

Sources: Old Ayala Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Old Ayala Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.